2m 2m 2m 2m 2m 2m 2m
Charles Riv Lab (CRL)
NYSE
$295.25+$0.06 (+0.02%)
Price as of Aug 21, 2026 7:38 PM EDT- $14.1BMarket Cap
- 82.40%1-Year Change
- Diagnostics & ResearchIndustry
Charles Riv Lab (CRL)
$295.25+$0.06 (+0.02%)
CRL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $295.19 | ||
Change | +$3.74 (+1.28%) | ||
Open | $291.78 | ||
High | $298.18 | ||
Low | $289.07 | ||
Previous Close | $291.45 | ||
Volume | 887,561 | ||
30-Day Average Volume | 944,655 | ||
1-Week Change | 5.41% | ||
1-Month Change | 34.54% | ||
1-Year Change | 82.40% | ||
3-Year Change | 46.93% | ||
5-Year Change | -30.50% | ||
Fundamentals | |||
Shares Outstanding | 47.7M | ||
Total Assets | $7.5B | ||
Market Cap | $14.1B | ||
Enterprise Value | $16.5B | ||
Period: QTR TTM FY | |||
Revenue | $808.3M | ||
Net Income | -$1.5M | ||
Free Cash Flow | $148.6M | ||
EBIT | $52.4M | ||
EBITDA | $119.7M | ||
Net Working Capital | $394.4M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | 138 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 5 | ||
P/E | -9,840 | ||
PEG | -109 | ||
Price/Free Cash Flow | 95 | ||
Price/Operating Cash Flow | 78 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue